OpenAlex
PricingAboutJobs
Log inGet started
Work

Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms

HTML

Year: 2019
Type: review
Source: Pharmacology Biochemistry and Behavior
DOI: 10.1016/j.pbb.2019.172827
Authors: Taro Kato, Ronald S. Duman
Institutions: Sumitomo Dainippon Pharma (Japan), Yale University
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: ketamine, antidepressant mechanism, NMDA receptor, positive allosteric modulators, rapid-acting antidepressants, depression, glutamatergic agents, dissociative anesthetics, cognitive impairment, psychotomimetic side effects
SDG: Good health and well-being

Open Access status: closed

Funders: Foundation for the National Institutes of Health, Eli Lilly and Company, Dainippon Sumitomo Pharma, H. Lundbeck A/S, Johnson and Johnson, Allergan, National Institute of Mental Health
Awards: Role of GABA Interneurons in the Rapid Antidepressant Actions of NMDA Receptor Blockade, Synaptic mechanisms underlying the rapid antidepressant actions of scopolamine
OpenAlex ID: W2988658447
FWCI: 0.721
Cites: 51
Cited by: 53
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security